Veno-occlusive disease of the liver

disorder

SNOMED 65617004CUI C0019156

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Human antithrombin III

substance

Defibrotide

substance

Defibrotide sodium

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abnormal liver enzymes

Very frequent (80-99%)HP:0002910

Ascites

Very frequent (80-99%)HP:0001541

Enlarged liver

Very frequent (80-99%)HP:0002240

Increased body weight

Very frequent (80-99%)HP:0004324

Increased total bilirubin

Very frequent (80-99%)HP:0003573

Renal failure in adulthood

Very frequent (80-99%)HP:0000083

Respiratory failure

Very frequent (80-99%)HP:0002878

Stomach pain

Very frequent (80-99%)HP:0002027

Yellowing of the skin

Very frequent (80-99%)HP:0000952

Abnormality of coagulation

Frequent (30-79%)HP:0001928

Prolonged activated partial thromboplastin time

Frequent (30-79%)HP:0003645

Hepatic encephalopathy

Very rare (1-4%)HP:0002480

Related Conditions

Hepatic veno-occlusive disease with immunodeficiency syndrome(child)

Abnormality of hepatic vein(parent)

Systemic vein obstruction(parent)

Obstruction of visceral vein(parent)

Quick Facts

SNOMED CT: 65617004
UMLS CUI: C0019156
Fully Specified Name: Veno-occlusive disease of the liver (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 12
Known Treatments: 3

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.